Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
The European Respiratory Journal|August 29, 2024
Treatment algorithm for pulmonary arterial hypertensionKelly M Chin, Sean P Gaine, Christian Gerges, et al.
Pulmonary Circulation|April 16, 2019
Barriers to physical activity in patients with pulmonary hypertensionThomas M Cascino, Vallerie V McLaughlin, Caroline R Richardson, et al.
Annals of the Rheumatic Diseases|October 15, 2011
The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAHPhilip J Clements, Mary Tan, Vallerie V McLaughlin, et al.
Circulation|March 7, 2024
Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart AssociationVikas Aggarwal, Jay Giri, Scott H Visovatti, et al.
The European Respiratory Journal|February 3, 2005
Survival with first-line bosentan in patients with primary pulmonary hypertensionV V McLaughlin, O Sitbon, D B Badesch, et al.
Chest|August 23, 2012
Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gapVallerie V McLaughlin, Anatoly Langer, Mary Tan, et al.
Cardiology and Therapy|March 7, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS DatasetRichard Channick, Kelly M Chin, Vallerie V McLaughlin, et al.
Advances in Therapy|November 19, 2025
Characteristics, Treatment Patterns and Outcomes of Patients with Pulmonary Arterial Hypertension by Race and Ethnicity Using Real-World Data from the Combined OPUS/OrPHeUS StudiesLana D Melendres-Groves, Richard N Channick, Kelly M Chin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 8, 2011
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extensionRaymond L Benza, Werner Seeger, Vallerie V McLaughlin, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Recognition of pulmonary hypertension in the rheumatology community: lessons from a Quality Enhancement Research InitiativeD Khanna, Ma Tan, D E Furst, et al.
Pageof 17